CPSC recall 22733
PhysiciansCare brand Aspirin, Extra Strength Non Aspirin, Extra Strength Pain Reliever, Ibuprofen, Medication Station, and Multi-Pack
- CPSC
- unknown
- Published 2022-03-17
On 2022-03-17 the CPSC announced a recall of PhysiciansCare brand Aspirin, Extra Strength Non Aspirin, Extra Strength Pain Reliever, Ibuprofen, Medication Station, and Multi-Pack by Acme United, citing the recalled over-the-counter products contain regulated substances (aspirin, acetaminophen, or ibuprofen) which must be in child resistant packaging when being used in the househ….
| Agency | CPSC |
|---|---|
| Recall number | 22733 |
| Classification | Not classified |
| Status | unknown |
| Initiated | 2022-03-17 |
| Published | 2022-03-17 |
| Last updated | 2026-09-13 11:58 UTC |
| Company | Acme United |
| Distribution | US |
Product
PhysiciansCare brand Aspirin, Extra Strength Non Aspirin, Extra Strength Pain Reliever, Ibuprofen, Medication Station, and Multi-Pack | This recall involves the PhysiciansCare brand Extra Strength Non Aspirin, Aspirin, Extra Strength Pain Reliever, Ibuprofen, Medication Station, and Multi-Pack over-the-counter drugs. The products contain aspirin, acetaminophen, or ibuprofen. They are packaged in cardboard boxes of 50, 100, 250, and 500 tablets per box. Product Drug Tablet Amount Extra Strength Non Aspirin Acetaminophen (500 mg) 50 tablets 100 tablets 250 tablets 500 tablets 2 boxes of 100 tablets each Aspirin Aspirin (325 mg) 50 tablets 100 tablets 250 tablets 500 tablets Extra Strength Pain Reliever Acetaminophen (250 mg) Aspirin (250 mg) 100 tablets 250 tablets Ibuprofen Ibuprofen (200 mg) 100 tablets 250 tablets 500 tablets 2 boxes of 100 tablets each Medication Station / Multi-Pack Acetaminophen (500 mg) Aspirin (325 mg) Ibuprofen (200 mg) Antacid (420 mg) 4 boxes of 100 tablets each with outer station 4 boxes of 100 tablets each without outer station The Antacid is not subject to this recall.
Reason
The recalled over-the-counter products contain regulated substances (aspirin, acetaminophen, or ibuprofen) which must be in child resistant packaging when being used in the household as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:58 UTC. Current status: unknown.
Source
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.